Last reviewed · How we verify
Regional Block 2: QL1 — Competitive Intelligence Brief
phase 3
Anesthesiology
Small molecule
Live · refreshed every 30 min
Target snapshot
Regional Block 2: QL1 (Regional Block 2: QL1) — Jennifer Holder-Murray. This drug is used to block nerve signals in a specific region of the body.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Regional Block 2: QL1 TARGET | Regional Block 2: QL1 | Jennifer Holder-Murray | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Regional Block 2: QL1 CI watch — RSS
- Regional Block 2: QL1 CI watch — Atom
- Regional Block 2: QL1 CI watch — JSON
- Regional Block 2: QL1 alone — RSS
Cite this brief
Drug Landscape (2026). Regional Block 2: QL1 — Competitive Intelligence Brief. https://druglandscape.com/ci/regional-block-2-ql1. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing